Age affects the prognostic impact of diabetes in chronic heart failure

Filipe Manuel Cunha1, Joana Pereira2, Ana Ribeiro2

  • 1Serviço de Endocrinologia, Centro Hospitalar de Trás-os-Montes e Alto Douro, Avenida da Noruega, 4202-451, Lordelo, Vila Real, Portugal. filipemrcunha@gmail.com.

Acta Diabetologica
|January 10, 2018
PubMed

Insights

Diabetes significantly increases mortality risk in younger heart failure (HF) patients under 75 years. However, this increased risk is not observed in older HF patients aged 75 and above.

Area of Science:

  • Cardiology
  • Geriatrics
  • Endocrinology

Background:

  • Increasing age is a known factor influencing prognosis in chronic heart failure (HF).
  • Diabetes mellitus frequently complicates the course of HF and is associated with a poorer prognosis.
  • The differential impact of diabetes on HF mortality based on patient age has not been extensively studied.

Purpose of the Study:

  • To evaluate the impact of diabetes on the all-cause mortality of patients with chronic heart failure (HF).
  • To investigate whether the prognostic significance of diabetes in HF differs between younger and older adult populations.

Main Methods:

  • A prospective cohort study of 283 ambulatory patients with chronic HF on optimized therapy was conducted.
  • Patients were followed for up to 5 years, with all-cause mortality as the primary endpoint.
  • Cox regression analysis, stratified by age (cutoff 75 years), was used to assess mortality predictors, with formal testing for interaction between diabetes and age.

Main Results:

  • In patients younger than 75 years, diabetes was associated with a multivariate adjusted 1.98-fold increased risk of 5-year mortality (95% CI 1.13-3.46).
  • In patients aged 75 years and older, no significant association between diabetes and 5-year mortality was found.
  • A significant interaction between age and the prognostic impact of diabetes on mortality was observed (p=0.04).

Conclusions:

  • The prognostic effect of diabetes on mortality in chronic HF patients is age-dependent.
  • Diabetes confers a significantly higher mortality risk in HF patients under 75 years old.
  • In contrast, diabetes does not appear to impact mortality risk in HF patients aged 75 years or older.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369